NeuroBo Pharmaceuticals, Inc. - Common Stock (NRBO)
2.3600
0.00 (0.00%)
Neurobo Pharmaceuticals is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases and other severe conditions
Through its cutting-edge research and development efforts, the company aims to create transformative treatments that address significant unmet medical needs in areas such as cognition, memory, and overall brain health. By harnessing advanced technology and scientific insights, Neurobo strives to improve patient outcomes and enhance the quality of life for individuals affected by debilitating neurological disorders.
Frequently Asked Questions
Is NeuroBo Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, NeuroBo Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does NeuroBo Pharmaceuticals, Inc. - Common Stock trade on?
NeuroBo Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeuroBo Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for NeuroBo Pharmaceuticals, Inc. - Common Stock is NRBO on the Nasdaq Stock Market
What is the current price of NeuroBo Pharmaceuticals, Inc. - Common Stock?
The current price of NeuroBo Pharmaceuticals, Inc. - Common Stock is 2.360
When was NeuroBo Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of NeuroBo Pharmaceuticals, Inc. - Common Stock was at 3:59 pm EST on November 27th, 2024
What is the market capitalization of NeuroBo Pharmaceuticals, Inc. - Common Stock?
The market capitalization of NeuroBo Pharmaceuticals, Inc. - Common Stock is 20.33M
How many shares of NeuroBo Pharmaceuticals, Inc. - Common Stock are outstanding?
NeuroBo Pharmaceuticals, Inc. - Common Stock has 8.62M shares outstanding.